首页|丁苯酞联合胞磷胆碱钠治疗急性脑梗死患者的效果

丁苯酞联合胞磷胆碱钠治疗急性脑梗死患者的效果

扫码查看
目的:观察丁苯酞联合胞磷胆碱钠治疗急性脑梗死患者的效果.方法:选取 2020 年 8 月至 2023 年 5 月该院收治的 86 例急性脑梗死患者进行前瞻性研究,按照随机数字表法将其分为研究组和对照组各 43 例.两组均予以基础治疗,在此基础上,对照组采用胞磷胆碱钠治疗,研究组在对照组基础上联合丁苯酞治疗,两组均治疗 1 周.比较两组临床疗效,治疗前后神经功能缺损[美国国立卫生研究院卒中量表(NIHSS)]评分、中枢神经特异性蛋白(S100β)水平、血液流变学指标[血浆黏度(PV)、全血低切黏度(LBV)]水平、血管内皮功能指标[内皮素-1(ET-1)、同型半胱氨酸(Hcy)、一氧化氮(NO)]水平,以及不良反应发生率.结果:研究组治疗总有效率为 93.02%(40/43),高于对照组的 76.74%(33/43),差异有统计学意义(P<0.05);治疗后,研究组NIHSS评分和S100β、PV、LBV水平均低于对照组,差异有统计学意义(P<0.05);治疗后,研究组NO水平高于对照组,ET-1、Hcy水平低于对照组,差异均有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:丁苯酞联合胞磷胆碱钠治疗急性脑梗死患者可提高治疗总有效率,降低神经功能缺损评分、S100β水平和血液流变学指标水平,改善血管内皮功能指标水平,效果优于单纯胞磷胆碱钠治疗.
Effects of Butylphthalide combined with Citicoline sodium in treatment of patients with acute cerebral infarction
Objective:To observe effects of Butylphthalide combined with Citicoline sodium in treatment of patients with acute cerebral infarction.Methods:A prospective study was conducted on 86 patients with acute cerebral infarction admitted to the hospital from August 2020 to May 2023.According to the random number table method,they were divided into study group and control group,43 cases in each group.Both groups were given the basic treatment.On this basis,the control group was treated with Citicoline sodium,while the study group was treated with Butylphthalide on the basis of that of the control group.Both groups were treated for 1 week.The clinical efficacy,the neurological deficit[National Institutes of Health stroke scale(NIHSS)]score,the central nervous system specific protein(S100β)level,the hemorheology index[plasma viscosity(PV),whole blood low shear viscosity(LBV)]levels,the vascular endothelial function index[endothelin-1(ET-1),homocysteine(Hcy),nitric oxide(NO)]levels before and after the treatment,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the study group was 93.02%(40/43),which was higher than 76.74%(33/43)of the control group,and the difference was statistically significant(P<0.05).After treatment,the NIHSS score and the levels of S100β,PV and LBV in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).After treatment,the level of NO in the study group was higher than that in the control group,the levels of ET-1 and Hcy were lower than those in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Butylphthalide combined with Citicoline sodium in the treatment of the patients with acute cerebral infarction can improve the total effective rate of treatment,reduce the neurological deficit scores,the S100β levels and the hemorheology index levels,and improve the levels of vascular endothelial function index.Moreover,it is superior to simple Citicoline sodium treatment.

ButylphthalideCiticoline sodiumAcute cerebral infarctionNeurological deficitVascular endothelial functionHemorheologyCentral nervous specific protein

郭锦、杨光、肖明明

展开 >

驻马店市中医院脑病二区,河南 驻马店 463000

丁苯酞 胞磷胆碱钠 急性脑梗死 神经功能缺损 血管内皮功能 血液流变学 中枢神经特异性蛋白

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(20)